Editor’s Letter

Published in:
Volume 9 / Year 2020 / Issue 1

Policy recommendations

Author(s):
Page: 3-4

The current coronavirus pandemic raises some important questions relevant to generic and/or biosimilar products. While still unproven, there are some indications that approved antiviral compounds exist which might be able… Read More »

Go Back Print